These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9333426)

  • 1. [Tirilazad mesylate (Freedox)--an effective inhibitor of lipid membrane peroxidation].
    Sániová B
    Bratisl Lek Listy; 1997 Jun; 98(6):339-42. PubMed ID: 9333426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation.
    Wang Y; Mathews WR; Guido DM; Jaeschke H
    J Pharmacol Exp Ther; 1996 May; 277(2):714-20. PubMed ID: 8627550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lipid peroxidation in central nervous system trauma and ischemia.
    Hall ED
    J Neurol Sci; 1995 Dec; 134 Suppl():79-83. PubMed ID: 8847548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic potential of lazaroids (21-aminosteroids). A recent survey].
    Buttgereit F; Hiepe F; Burmester GR
    Dtsch Med Wochenschr; 1997 Oct; 122(44):1363-7. PubMed ID: 9410710
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage.
    Hall ED
    Eur J Anaesthesiol; 1996 May; 13(3):279-89. PubMed ID: 8737119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders.
    Hall ED
    Ann Neurol; 1992; 32 Suppl():S137-42. PubMed ID: 1510373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of the 21-aminosteroid lazaroid tirilazad mesylate (PNU-74006F) and the pyrrolopyrimidine lazaroid PNU-101033E on energy metabolism of human peripheral blood mononuclear cells.
    Schmid D; Burmester GR; Tripmacher R; Fici G; von Voigtlander P; Buttgereit F
    Biosci Rep; 2001 Feb; 21(1):101-10. PubMed ID: 11508689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lazaroid tirilazad is a new inhibitor of direct and indirect UVA-induced lipid peroxidation in human dermal fibroblasts.
    Dissemond J; Schneider LA; Wlaschek M; Brauns TC; Goos M; Scharffetter-Kochanek K
    Arch Dermatol Res; 2003 Dec; 295(7):287-92. PubMed ID: 14593485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 21-aminosteroid 16-desmethyl tirilazad mesylate prevents necroinflammatory changes in experimental alcoholic liver disease.
    Sadrzadeh SM; Nanji AA
    J Pharmacol Exp Ther; 1998 Jan; 284(1):406-12. PubMed ID: 9435204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.
    Hall ED; McCall JM; Means ED
    Adv Pharmacol; 1994; 28():221-68. PubMed ID: 8080818
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
    Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL
    Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibilities of brain protection with tirilazad after cardiac arrest.
    Sterz F; Janata K; Kürkciyan I; Müllner M; Malzer R; Schreiber W
    Semin Thromb Hemost; 1996; 22(1):105-12. PubMed ID: 8711485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a 21-aminosteroid against hemorrhage-induced ischemia-reperfusion injury in the rat stomach: role of lipid peroxidation.
    Cross JM; Smith GS; Russell DH; Nguyen PH; Mercer DW; Barreto JC; Miller TA
    Shock; 1995 May; 3(5):385-90. PubMed ID: 7648342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
    Smith SL; Scherch HM; Hall ED
    J Neurosurg; 1996 Feb; 84(2):229-33. PubMed ID: 8592225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of tirilazad mesylate in a cellular model of peroxynitrite toxicity.
    Fici GJ; Althaus JS; Hall ED; Von Voigtlander PF
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):357-71. PubMed ID: 8829775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of a 21-aminosteroid against copper-induced erythrocyte and plasma lipid peroxidation.
    Fernandes AC; Filipe PM; Manso CF
    Eur J Pharmacol; 1992 Sep; 220(2-3):211-6. PubMed ID: 1425992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection.
    Kavanagh RJ; Kam PC
    Br J Anaesth; 2001 Jan; 86(1):110-9. PubMed ID: 11575384
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effects of lazaroid U74389F (16-desmethyl tirilazad) on endrin-induced lipid peroxidation and DNA damage in brain and liver and regional distribution of catalase activity in rat brain.
    Bagchi M; Ghosh S; Bagchi D; Hassoun E; Stohs SJ
    Free Radic Biol Med; 1995 Dec; 19(6):867-72. PubMed ID: 8582661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.